HESHAM MOHAMED to Time Factors
This is a "connection" page, showing publications HESHAM MOHAMED has written about Time Factors.
Connection Strength
0.013
-
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). Blood. 2014 Jan 23; 123(4):494-500.
Score: 0.013